Imagine a tiny, soft, wireless cable that acts like a high-tech bridge between the brain and the spinal cord. It can both listen to the body's signals and send instructions back in real-time. This helps scientists understand exactly how we move and how to fix the connection when it's broken by a stroke.
Over 1 billion people suffer from movement-related neurological diseases, and 1.5 million EU citizens suffer strokes annually. Current treatments lack the precision and biocompatibility needed to effectively restore brain-spinal cord communication.
A bi-directional, wireless, soft-fiber neural interface and a theoretical model for movement generation. A first tethered prototype of the packaging has been designed.
If you are a neuroprosthetics manufacturer dealing with rigid, invasive implants that cause tissue damage — this project developed a soft-fiber platform that provides a minimally invasive, biocompatible interface. This allows for high-resolution stimulation and recording in living subjects.
If you are a drug discovery firm dealing with the inability to map real-time brain-spinal cord interactions during treatment — this project developed a bi-directional interface to map neuronal circuits. This enables precise validation of theories on movement generation in disease models.
If you are a rehabilitation provider dealing with the lack of effective tools for the 1.5 million stroke victims in the EU — this project developed the basis for a next-generation nervous system pacemaker. This could lead to precision sensing and treatment for paralysis and disability.
Based on available project data, there is no information regarding the production cost or market price of the neural interface.
The project is currently in the early stages, having identified optical materials and tested polymer fibers. Based on available project data, industrial scaling has not yet been addressed.
Based on available project data, specific patent filings or licensing terms are not listed, though the project aims to establish European technological sovereignty.
The project runs from 2024-07-01 to 2027-06-30. Given it is currently validating theories and prototypes in rodents, a commercial timeline is not yet defined.
The system uses a minimally invasive, wireless, and biocompatible soft multifunctional fiber that is implanted to allow simultaneous stimulation and recording.
The consortium is purely academic, consisting of 4 university partners across 3 countries (Denmark, Germany, Cyprus). There are 0 industry partners and 0 SMEs, indicating the project is currently focused on high-risk, disruptive research rather than immediate commercialization.
Contact Danmarks Tekniske Universitet (DTU) regarding the optoelectronic fiber implant development.
Contact us to find potential industrial partners for the transition from prototype to clinical pilot.
